Bob Martin Clear Spot On Solution 268mg For Large Dogs
Revised: March 2016
AN: 01250/2015
SUMMARY OF PRODUCT CHARACTERISTICS
NAME OF THE VETERINARY MEDICINAL PRODUCT
Bob Martin Clear Spot On Solution 268mg for Large Dogs
QUALITATIVE AND QUANTITATIVE COMPOSITION
One 2.68 ml tube contains:
Active substance:
Fipronil 268mg
Excipients:
Butyhydroxyanisole E320 0.536mg
Butylhydroxytoluene E321 0.268mg
For the full list of excipients, see section 6.1.
PHARMACEUTICAL FORM
Spot-on solution.
Clear, pale amber solution.
CLINICAL PARTICULARS
Target species
Dogs.
Indications for use
Treatment of
flea (Ctenocephalidesspp.) and tick (Rhipicephalus
sanguineus[the brown dog tick] and
Ixodes ricinus [the
castor bean or sheep tick])
infestations.
This product
protects against new infestations with adult fleas for 8 weeks.
The product offers protection for 4 weeks against ticks
(Rhipicephalus
sanguineus, Ixodes
ricinus, Dermacentor reticulatus[European
meadow tick]).
If ticks of some species (Dermacentorreticulatus) are already present when the product is applied, all of the ticks may not be killed within the first 48 hours.
Contraindications (when not to use the product)
Do not use on puppies less than 2 months old and /or weighing less than 2kg.
Do not use in rabbits!Adverse drug reactions and even death could occur. This product is specifically developed for dogs. Do not use in cats, as this could lead to overdosing.
Do not use on animals with known hypersensitivity to the active substance or to any of the excipients.
Do not use in animals that are unwell, are undergoing treatment for or are recovering from illness.
Special warnings for each target species
Avoid frequent swimming or shampooing the animal because the maintenance of effectiveness of the product in these cases has not been tested.
The product does not prevent ticks from attaching to the animals. If the animal has been treated prior to exposure to the ticks, the ticks will be killed in the first 24-48 hours after attachment. This will usually be prior to their having fed, minimising but not excluding the risk of transmission of diseases. Once dead, ticks will often drop off the animal, but any remaining ticks may be removed with a gentle twist.
Fleas from pets often infest the animal's basket, bedding and regular resting areas such as carpets and soft furnishings which should be treated, in case of massive infestation and at the beginning of the control measures, with a suitable insecticide and vacuumed regularly.
For optimal control of flea infestation in multi-pet household, all dogs and cats in the household should be treated with a suitable insecticide.
Special precautions for use
Special precautions for use in animals
Animals should be weighed accurately prior to treatment.
Avoid contact with the animal’s eyes. In the case of accidental eye contact, immediately and thoroughly flush the eyes with water.
It is important to make sure that the product is applied to an area where the animal cannot lick it off, and to make sure that animals do not lick each other following treatment.
Do not apply the product on wounds or damaged skin.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
This product can cause mucous membrane and eye irritation. Therefore, contact between the product and the mouth or eyes should be avoided.
In the case of accidental eye contact, immediately and thoroughly flush the eyes with water. If eye irritation persists seek medical advice and show the package leaflet or the label to the physician.
Do not smoke, drink or eat during application.
Avoid contents coming into contact with the fingers. If this occurs, wash hands with soap and water. Wash hands after use.
People with a known hypersensitivity to fipronil or any of the other ingredients should avoid contact with the product.
Treated animals should not be handled until the application site is dry, and children should not be allowed to play with treated animals until the application site is dry. It is therefore recommended that animals are not treated during the day, but should be treated during the early evening, and that recently treated animals should not be allowed to sleep with owners, especially children.
Other precautions
Fipronil may adversely affect aquatic organisms. Dogs should not be allowed to swim in water courses for 2 days after application.
The product may have adverse effects on painted, varnished or other household surfaces or furnishings.
Adverse reactions (frequency and seriousness)
If licking occurs, a brief period of excessive salivation / drooling may be observed due mainly to the solvents in the product.
Among the extremely rare suspected adverse reactions, short duration skin reactions at the application site (scaly skin, hair loss at the application site, skin irritation and reddening) and general skin irritation or hair loss have been reported after use. Rarely, excessive drooling / salivation, short-term and reversible nervous signs (e.g. excitability, depression) or vomiting have been observed after use.
Use during pregnancy and lactation
Not recommended for use in pregnant dogs/cats or where the dog/cat is providing milk for puppies/kittens. If in doubt, seek the advice of your usual veterinary surgeon.
Interaction with other medicinal products and other forms of interaction
None known.
Amounts to be administered and administration route
Route of administration and dosage:
External use only. Administer by topical application to the skin according to the bodyweight as follows: 1 tube of 2.68 ml per dog weighing over 20 kg and up to 40 kg bodyweight.
Method of administration:
Remove the tube from the blister packaging. Hold the tube in an upright position and snap off the top section of the cap, thereby opening the tube.
Part your dog’s coat until the skin is visible. Place the tip of the tube directly against the bared skin and squeeze gently. Empty approximately half the contents at each of two points along the dog’s back, preferably at the base of the head and between the shoulder blades. Squeeze the tube several times to ensure dosing is complete. Avoid applying the solution onto the fur and do not rub into the skin.
Application of the solution as directed minimises the possibility that the animal will lick the solution off. Do not allow pets to lick each other after treatment.
Care should be taken to avoid excessive wetting of the hair with the product since this will cause a sticky appearance of hairs at the treatment spot. However, should this occur, it will usually disappear within 24-48 hours post application. Crystals may be seen on the hair and slight scaling may occur within 24-48 hours after application.
Where treating young animals, do not use this product on puppies of less than 2 months of age. Weigh the puppy firstand ensure that the correct product is used based on the weight of the puppy. This product would treat a puppy weighing 20 - 40kg. Do not use on puppies weighing less than 20kg.
For dogs over 60kg use two2.68ml tubes 268mg Fipronil (Bob Martin Clear Spot On Solution 268mg for Large Dogs).
Treatment schedule:
The minimum interval between two treatments is 4 weeks, but longer intervals may be appropriate in some cases. For advice speak to your veterinary surgeon.
Overdose (symptoms, emergency procedures, antidotes), if necessary
No adverse effects were observed in safety studies in 2 month-old puppies, growing dogs and dogs weighing about 2 kg treated with 5 times the recommended dose once a month for 3 consecutive months. The risk of adverse effects (see section 4.6) may increase in cases of overdose. Be certain to select and use the correct product for your pet.
Withdrawal period
Not applicable.
PHARMACOLOGICAL PROPERTIES
Pharmacotherapeutic group:Ectoparasiticides for topical use.
ATCVet Code:QP53AX15
Pharmacodynamic properties
Fipronil is an insecticide and acaricide belonging to the phenylpyrazole family. It acts by inhibiting the GABA complex, binding to the chloride channel and thereby blocking pre- and post-synaptic transfer of chloride ions across cell membranes. This results in uncontrolled activity of the central nervous system and death of insects or acarids.
Fipronil exhibits an insecticidal and acaricidal activity against fleas (Ctenocephalidesspp), ticks (Rhipicephalusspp, Ixodesspp including Ixodesricinus) in the dog.
Fleas will be killed within 24 h. Ticks will usually be killed within 48 h after contact with Fipronil, however if ticks of some species (Dermacentorreticulatus) are already present when the product is applied, all of the ticks may not be killed within the first 48 hours.
Pharmacokinetic particulars
Fipronil is mainly metabolised to its sulfone derivative (RM1602), which also possesses insecticidal and acaricidal properties. The concentrations of fipronil on the hair decrease with time.
PHARMACEUTICAL PARTICULARS
List of excipients (other ingredients)
Butylhydroxyanisole E320
Butylhydroxytoluene E321
Propylene glycol
Benzyl alcohol
Diethylene glycol monoethyl ether
Incompatibilities
None known.
Shelf life
Shelf-life of the veterinary medicinal product as packaged for sale: 2 years.
Special precautions for storage
Store below 25C, in a dry place in the original packaging.
Nature and composition of immediate packaging
White opaque or purple or pink translucent polypropylene single-dose tubes containing an extractable volume of 2.68 ml packaged in a clear PVC blister closed by heat sealing with aluminium foil and placed in a carton box or blister card.
Blister cards or boxes of 1, 2, 3, 4, 5 or 6 tubes.
Not all pack sizes may be marketed.
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. Fipronil may adversely affect aquatic organisms. Do not contaminate ponds, waterways or ditches with the product or empty container.
MARKETING AUTHORISATION HOLDER
Bob Martin (UK) Ltd
Wemberham Lane
Yatton
North Somerset
BS49 4BS
MARKETING AUTHORISATION NUMBER
Vm 00715/4116
DATE OF FIRST AUTHORISATION
27 May 2011
DATE OF REVISION OF THE TEXT
March 2016
Approved: 23 March 2016
Page 10 of 10